Karalexi M A, Dessypris N, Skalkidou A, Biniaris-Georgallis S -I, Kalogirou Ε Ι, Thomopoulos T P, Herlenius E, Spector L G, Loutradis D, Chrousos G P, Petridou E Th
Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, University of Athens, 75 Mikras Asias Str, 11527, Athens, Greece.
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Cancer Causes Control. 2017 Jun;28(6):599-624. doi: 10.1007/s10552-017-0890-2. Epub 2017 Apr 11.
History of fetal loss including miscarriage and stillbirth has been inconsistently associated with childhood (0-14 years) leukemia in subsequent offspring. A quantitative synthesis of the inconclusive literature by leukemia subtype was therefore conducted.
Eligible studies (N = 32) were identified through the screening of over 3500 publications. Random-effects meta-analyses were conducted on the association of miscarriage/stillbirth history with overall (AL; 18,868 cases/35,685 controls), acute lymphoblastic (ALL; 16,150 cases/38,655 controls), and myeloid (AML; 3042 cases/32,997 controls) leukemia. Sensitivity and subgroup analyses by age and ALL subtype, as well as meta-regression were undertaken.
Fetal loss history was associated with increased AL risk [Odds Ratio (OR) 1.10, 95% Confidence Intervals (CI) 1.04-1.18]. The positive association was seen for ALL (OR 1.12, 95%CI 1.05-1.19) and for AML (OR 1.13, 95%CI 0.91-1.41); for the latter the OR increased in sensitivity analyses. Notably, stillbirth history was significantly linked to ALL risk (OR 1.33, 95%CI 1.02-1.74), but not AML. By contrast, the association of ALL and AML with previous miscarriage reached marginal significance. The association of miscarriage history was strongest in infant ALL (OR 2.34, 95%CI 1.19-4.60).
In this meta-analysis involving >50,000 children, we found noteworthy associations by indices of fetal loss, age at diagnosis, and leukemia type; namely, of stillbirth with ALL and miscarriage history with infant ALL. Elucidation of plausible underlying mechanisms may provide insight into leukemia pathogenesis and indicate monitoring interventions prior to and during pregnancy.
胎儿丢失史,包括流产和死产,与随后子代儿童期(0 - 14岁)白血病之间的关联一直存在争议。因此,我们对尚无定论的文献按白血病亚型进行了定量综合分析。
通过筛选3500多篇出版物,确定了符合条件的研究(N = 32项)。对流产/死产史与总体白血病(AL;18868例/35685例对照)、急性淋巴细胞白血病(ALL;16150例/38655例对照)和髓系白血病(AML;3042例/32997例对照)之间的关联进行随机效应荟萃分析。进行了按年龄和ALL亚型的敏感性和亚组分析,以及meta回归分析。
胎儿丢失史与AL风险增加相关[比值比(OR)1.10,95%置信区间(CI)1.04 - 1.18]。ALL(OR 1.12,95%CI 1.05 - 1.19)和AML(OR 1.13,95%CI 0.91 - 1.41)也存在正相关;在敏感性分析中,AML的OR有所增加。值得注意的是,死产史与ALL风险显著相关(OR 1.33,95%CI 1.02 - 1.74),但与AML无关。相比之下,ALL和AML与既往流产之间的关联达到边缘显著性。流产史与婴儿ALL的关联最为强烈(OR 2.34,95%CI 1.19 - 4.60)。
在这项涉及超过50000名儿童的荟萃分析中,我们发现胎儿丢失指标、诊断年龄和白血病类型之间存在值得关注的关联;即死产与ALL以及流产史与婴儿ALL之间的关联。阐明可能的潜在机制可能有助于深入了解白血病发病机制,并提示孕期及孕前的监测干预措施。